1msx: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
==HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL)PHENOXY]-3, 5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS.== | ==HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL)PHENOXY]-3, 5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS.== | ||
<StructureSection load='1msx' size='340' side='right' caption='[[1msx]]' scene=''> | <StructureSection load='1msx' size='340' side='right'caption='[[1msx]]' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1MSX FirstGlance]. <br> | <table><tr><td colspan='2'>For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1MSX FirstGlance]. <br> | ||
| Line 10: | Line 10: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Theoretical Model]] | [[Category: Theoretical Model]] | ||
[[Category: Large Structures]] | |||
[[Category: Dallas, J L]] | [[Category: Dallas, J L]] | ||
[[Category: Guilford, W J]] | [[Category: Guilford, W J]] | ||
Revision as of 18:47, 20 November 2019
 |
HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N-AMINO-15N-IMINO- 13C-METHYL)PHENOXY]-6-[3-(15N-AMINO-13C-METHYL)PHENOXY]-3, 5-DIFLUORO-4-METHYLPYRIDINE (ZK-806299), BINDING MODEL FROM DOUBLE REDOR NMR AND MD SIMULATIONS.
| ||||||||||||
